ClinicalTrials.gg
RecruitingNCT03364660TSEPIUpdated Aug 28, 2024

Task-specific Epidural Stimulation Study

An interventional study of Acute epidural stimulation for cardiovascular stability and Long Term Epidural Stimulation for Cardiovascular Stability in Spinal Cord Injuries, sponsored by University of Louisville. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-28.

Sponsored by University of Louisville · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Nov 2017; still recruiting 9 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Spinal Cord Injuries by University of Louisville — 9 open to participants now, 13 under way, none of them phase 3. Spinal Cord Injuries · University of Louisville.

Planned enrollment
4th of 20
36 · median 12
Started
2017
the only one that year
No phase
18 of 22
9 open now
Primary completion
2024-12
later than 2 of 12 live
Registered
6th of 22
by date

Among the 22 studies in Spinal Cord Injuries by University of Louisville, this one is the 4th largest by planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2017, is one of 18 with no phase, reaches primary completion later than 2 of the 12 other live ones, and was the 6th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

9 of the 22 studies in Spinal Cord Injuries by University of Louisville are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Spinal Cord Injuries by University of Louisville, or all of them as a file.
02

Study summary

The investigators propose to understand the role of lumbosacral spinal cord epidural stimulation (scES) in recovery of autonomic nervous system function, voluntary movement, and standing in individuals with severe spinal cord injury (SCI). Thirty-six individuals with severe SCI who have cardiovascular and respiratory dysfunction and who are unable to voluntarily move the legs or stand will receive scES for cardiovascular function, voluntary movement, or standing with and/or without weight-bearing standing. Training will consist of practicing voluntary movements or standing in the presence of specific scES configurations designed for the voluntary movements of the legs and trunk (Vol-scES), or epidural stimulation configurations specific for standing (Stand-scES). Specific configurations epidural stimulation for cardiovascular function (CV-scES) will be provided during sitting and supine and during maneuvers of orthostatic or cardiovascular stress. The ability to move voluntarily, stand, as well as cardiovascular, respiratory, bladder, bowel and sexual function will be assessed in these individuals with chronic severe spinal cord injury. Quality of life and costs of health care also will be assessed.

Read the detailed description

Experimental Design

The investigators will enroll, implant and complete the interventions in 36 research participants who have sustained a SCI in the proposed experiments. The investigators anticipate they will need to screen 108 potential research participants to enroll 36 individuals who will complete the study. This sample size will provide sufficient replication per study group (n=4) from which variance and effect size estimates for each study hypothesis can be calculated, and hypothesis tests conducted. The investigators will also select individuals to assure that there are a minimum of 25% (n=9) women to adequately represent the percentage in the SCI population. The investigators will study each cohort of patients comprehensively, and each individual will be allocated to the group interventions based on the method of minimization. Research participants will be randomized into group interventions. This novel approach of conducting repeated experiments with comprehensive assessments in a smaller cohort of patients, rather than a more traditional approach of including a large number of patients and focusing on a single outcome, will advance both clinical and scientific knowledge in this highly complex population. The investigators have found success with the smaller cohort approach because they can employ more rigorous, quantitative and sensitive outcomes that not only inform them about the potential clinical efficacy, but also provide further knowledge of the mechanisms of neural control of movement and other physiological mechanisms related to cardiovascular, respiratory, bladder, bowel and sexual function.

Group A:

  • Vol-scES during voluntary leg movement training while sitting or lying supine (A1).
  • CV-scES during sitting or lying supine (A2).

Group B:

  • Vol-scES during voluntary leg movement training + Stand-ES during stand training (B1).
  • CV-ES during sitting or lying supine + Stand-ES during stand training (B2).
03

Conditions studied

  • Spinal Cord Injuries

Keywords

  • Epidural Stimulation
  • Spinal Cord Injury
  • Task-Specific
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years of age
  • Non-progressive spinal cord injury
  • At least 2 years post injury
  • Stable medical condition
  • Unable to voluntarily move all individual joints of the legs
  • Unable to stand independently
  • Cardiovascular dysfunction including presence of persistent low blood pressures and/or symptoms of autonomic dysreflexia and/or orthostatic hypotension and/or dysregulation in response to postural changes and/or highly variable blood pressures in a 24 hour period
  • Urodynamic dysfunction including dyssynergia and/or inability to void voluntarily and/or low voiding capacity
  • Respiratory dysfunction including at least 15% deficit in predicted pulmonary function outcomes

Exclusion criteria

Exclusion Criteria:

  • Ventilator dependent
  • Untreated painful musculoskeletal dysfunction, fracture or pressure sore
  • Untreated psychiatric disorder or ongoing drug abuse
  • Cardiovascular, respiratory, bladder, or renal disease unrelated to spinal cord injury
  • Bladder botox injections less than 12 months prior to implant
  • Colostomy bag, urostomy
  • Any implanted pump (i.e., baclofen pump, pain pump, etc)
  • Ongoing nicotine use
  • Pregnant at the time of enrollment or planning to become pregnant during the time course of the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Acute Epidural Stimulation for Cardiovascular Stability.

    Participants are assessed both with and without epidural stimulation for cardiovascular stability for persistent hypotension, orthostatic hypotension and autonomic dysreflexia.

    Device: Acute epidural stimulation for cardiovascular stability

  • Experimental
    Epidural Stimulation for Cardiovascular stability during daily activities

    Participants assigned to this arm will receive be randomized to receive epidural stimulation specific for cardiovascular function alone or cardiovascular function and standing, or voluntary movement alone or voluntary movement and standing.

    Device: Long Term Epidural Stimulation for Cardiovascular Stability

  • Experimental
    Voluntary Movement ES + Stand Training

    Participants assigned to this group will receive epidural stimulation specific for voluntary movement and will also receive stand training.

    Device: Participants undergo approximately 4 months of epidural stimulation for voluntary movement plus stand training.

  • Experimental
    Cardiovascular ES + Stand Training

    Participants assigned to this group will receive epidural stimulation specific for cardiovascular function and will also receive stand training.

    Device: Long Term Epidural Stimulation for Cardiovascular Stability plus Stand Training

  • Experimental
    Epidural Stimulation for Voluntary Movement

    Participants assigned to this group receive epidural stimulation specifically for voluntary movement.

    Device: Participants undergo approximately 4 months of epidural stimulation for voluntary movement.

Interventions

  • DeviceAcute epidural stimulation for cardiovascular stability

    Eligible participants will be implanted with 16-electrode epidural array and epidural stimulator in the spinal cord. Participants received mapping for cardiovascular stability.

  • DeviceLong Term Epidural Stimulation for Cardiovascular Stability

    Participants undergo approximately 4 months of epidural stimulation for cardiovascular stability, daily.

  • DeviceParticipants undergo approximately 4 months of epidural stimulation for voluntary movement.

    Participants undergo approximately 4 months of epidural stimulation for voluntary movement 4-7 days weekly.

  • DeviceLong Term Epidural Stimulation for Cardiovascular Stability plus Stand Training

    Participants undergo approximately 4 months of epidural stimulation for cardiovascular stability, daily. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly.

  • DeviceParticipants undergo approximately 4 months of epidural stimulation for voluntary movement plus stand training.

    Participants undergo approximately 4 months of epidural stimulation for voluntary movement, 4-7 days weekly. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly.

06

What researchers measure

Primary outcomes

  1. Recovery of autonomic control of cardiovascular function as assessed by cardiovascular assessments

    Time frame: up to 20 months

  2. Recovery of voluntary movement as assessed by functional movement assessments

    Time frame: up to 20 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — There is no plan to share individual participant data.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2017 (actual). Primary completion is estimated for Dec 2024, 85 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 85 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2017
First posted
Dec 6, 2017
StartActual
Nov 8, 2017
Primary completionEst.
Dec 30, 2024
CompletionEst.
Dec 30, 2024
Last update
Aug 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03364660
Collaborators
Christopher Reeve Paralysis Foundation
Responsible party
Susan Harkema PhD (Professor, University of Louisville) — Principal investigator
First posted
Dec 6, 2017
Start date
Nov 8, 2017
Primary completion
Dec 30, 2024 (estimated)
Completion
Dec 30, 2024 (estimated)
Last update
Aug 28, 2024

Study contacts

Susan J Harkema, PhD
Contact
susan.harkema@louisville.edu
502-582-7443
Manpreet A Chopra, BAMS
Contact
manpreet.chopra@louisville.edu
502-582-7443
Susan J Harkema, PhD
principal investigator · University of Louisville

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion